On the afternoon of January 8, at Ho Guom Opera House (Hanoi), DHG Pharma was once again honored in the Top 10 Most Reputable Pharmaceutical Companies in 2025, marking nine consecutive years of maintaining its leading position in Vietnam’s pharmaceutical industry in terms of reputation and quality. This achievement affirms the company’s sustainable development strategy, strong financial capacity, and the lasting trust DHG Pharma has built with customers, partners, and the community.
Mr. Nguyen Manh Thang, Director of External Relations, representing DHG Pharma, received the award for the Top 10 Most Reputable Pharmaceutical Companies in 2025.
The ranking is conducted by Vietnam Report based on stringent criteria, including financial capacity, media reputation, and market credibility. Being consistently listed in the Top 10 for nearly a decade demonstrates DHG Pharma’s pioneering role and stable development foundation in Vietnam’s domestic pharmaceutical industry.
In 2025, DHG Pharma is expected to fulfill the business targets assigned by the General Meeting of Shareholders, continuing to maintain stable growth momentum amid a market that still faces many challenges.
One of DHG Pharma’s important milestones in December 2025 is the ceremony announcing that its Beta-lactam factory has achieved EU-GMP international standards (Good Manufacturing Practice according to European regulations), considered one of the world’s most stringent pharmaceutical quality standards. This milestone confirms that the domestic pharmaceutical enterprise owns two factories—Beta-lactam and Non-Beta-lactam—both meeting dual standards of Japan GMP and EU-GMP, affirming its production capabilities and quality control in line with international standards. This is an important milestone in continuous improvement efforts to better serve public healthcare.
DHG Pharma continues to reaffirm its commitment to the mission of caring for community health by providing safe, effective, and internationally standardized pharmaceutical products, while actively contributing to the goal of elevating Vietnam’s pharmaceutical industry on the regional and global map.
DHG Pharma’s manufacturing plants not only provide safe, high-quality products for consumers but also increasingly meet the growing demand for “international-quality domestically produced medicines” from the local hospital system. Achieving EU-GMP standards gives doctors and pharmacists greater confidence in prescribing, while also helping reduce dependence on imported medicines and easing the burden of treatment costs for patients.
In parallel with being ranked in the Top 10 Most Reputable Pharmaceutical Companies, over the past year DHG Pharma has continuously been recognized in many other prestigious rankings: 14 consecutive years in the Top 5 Most Efficient Business Companies in Vietnam (selected by Nhip Cau Dau Tu), 13 consecutive years in the Top 50 Best Listed Companies in Vietnam (selected by Forbes Vietnam), Top 100 Best Places to Work in Vietnam - large enterprises category (selected by Anphabe), Top 10 Best Corporate Governance Companies (mid-cap group), and Top 100 Sustainable Businesses CSI 2025, among others affirming its strong corporate governance quality and operational efficiency.
With these outstanding achievements, DHG Pharma continues to reaffirm its strong commitment to its mission of caring for community health, providing safe, effective pharmaceutical products that meet international standards, while actively contributing to elevating Vietnam’s pharmaceutical industry in the regional and global landscape. This also serves as a foundation for DHG Pharma to continuously improve and aim for higher development milestones in its journey for Vietnamese health, under the mission: “For a more beautiful and healthier life.”
